We can't find the internet
Attempting to reconnect
17451.1 PFLS-LS
17451.1 PFLS-LS
Zusammenfassung
Discovery and Development of Novel Drug Candidates for the Treatment of Diabetes
Weitere Texte
Abstract
G-protein coupled receptors (GPCR) are the target of close to half of marketed drugs. Growing|awareness that a single GPCR can govern multiple response pathways has opened the door|for the next generation of GPCR therapeutics that act as differentiated drugs. We combine cell signaling excellence and industrial drug development experience to build an innovative GPCR platform to radically refine molecule development for key pharmaceutical targets, and apply the|platform to discover first-in-class small molecule therapeutics for Diabetes.
Beteiligte
Daniel Fitzgerald
Wirtschaftspartner
df@geneva-biotech.com
GBiotech Sarl (DBA Geneva Biotech) Daniel Fitzgerald Avenue de la Roseraie 64 1205 Genève GE CH
Pierre Maechler
Kontaktperson
Pierre.Maechler@unige.ch
Université de Genève Pierre Maechler Rue du Général Dufour 24 1211 Genève GE CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2015-05-31
- Enddatum
- 2018-11-30
- Bewilligte Gesamtkosten
- CHF 477780.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%